10.01.06
DSM Venturing Invests in Skin Care Company
DSM Venturing, Geleen, The Netherlands, has invested $2 million in Sol-Gel Technologies Ltd., Bet Shemesh, Israel. Sol-Gel’s technology platform is of interest to DSM for further development of skin care and dermatology applications as part of its ambitions in the field of personal care. Sol-Gel develops ingredients for sunscreens, anti-acne and anti-aging products, which are based on proprietary technology. This technology enables room temperature entrapment of organic and bioactive molecules in silica glass beads. The ingredients can thereby be safely isolated and their delivery carefully controlled. The company has received exclusive worldwide licenses and patents, plus patents pending, for this technology. In addition to the investment, DSM and Sol-Gel Technologies intend to explore possible joint development activities and other collaborations, not only in the field of personal care but also in the animal and human nutrition markets.
DSM Venturing, Geleen, The Netherlands, has invested $2 million in Sol-Gel Technologies Ltd., Bet Shemesh, Israel. Sol-Gel’s technology platform is of interest to DSM for further development of skin care and dermatology applications as part of its ambitions in the field of personal care. Sol-Gel develops ingredients for sunscreens, anti-acne and anti-aging products, which are based on proprietary technology. This technology enables room temperature entrapment of organic and bioactive molecules in silica glass beads. The ingredients can thereby be safely isolated and their delivery carefully controlled. The company has received exclusive worldwide licenses and patents, plus patents pending, for this technology. In addition to the investment, DSM and Sol-Gel Technologies intend to explore possible joint development activities and other collaborations, not only in the field of personal care but also in the animal and human nutrition markets.